Cognitive Behavioral Therapy for Depression: Helping Clients Learn New Skills
1 other identifier
interventional
150
1 country
1
Brief Summary
The purpose of this study is to compare two psychological treatments for major depressive disorder (MDD): cognitive-behavioral therapy (CBT) and CBT-Skill Enhanced (CBT-SE). CBT is well-studied, research-supported treatment for depression. CBT-SE is a variant of CBT that places greater focus on helping clients to developing the skills of CBT. The study will enroll 150 participants with MDD. Participants will be randomized to CBT or CBT-SE, with 75 participants being assigned to each condition. For both conditions, treatment will be provided over 12 weeks, with a 6 month follow-up period. Potential participants are asked to complete an initial screening and an intake evaluation to determine eligibility. After entering the study, participants are asked to complete evaluations at 4 weeks and at 12 weeks. They are also asked to respond to self-report instruments before and after each session. Following the 12 week treatment, participants are asked to complete monthly follow-up surveys for 6 months. The primary objectives of this study are three-fold. The first is to compare the outcomes of the two treatments. The second is to evaluate potential mediators of any treatment differences. The third is to evaluate the process of change in these two versions of CBT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Dec 2020
Typical duration for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 11, 2020
CompletedFirst Submitted
Initial submission to the registry
December 12, 2020
CompletedFirst Posted
Study publicly available on registry
December 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 19, 2023
CompletedApril 18, 2024
April 1, 2024
1.9 years
December 12, 2020
April 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in Quick Inventory of Depressive Symptoms-Self-Report at week 12.
The Quick Inventory of Depressive Symptoms-Self-Report is a 16-item self-report measure of depressive symptoms. Scores range from 0 to 27, with higher scores indicating greater depressive symptoms.
Weeks 0-12, assessments occurred at every session through week 12.
Change in Cognitive Change Sustained at week 12.
The Cognitive Change Sustained is a 9-item measure designed to assess the degree to which experienced cognitive change and used cognitive and behavioral strategies in the days leading up to their session. Scores range from 0 to 54, with a higher score indicating greater cognitive change.
Weeks 0-12, assessments occurred at every session aside from session 1 through week 12.
Change in Ways of Responding Scale at week 12.
The Ways of Responding Scale is a measure of the skills taught in CBT for depression. Participants respond to 6 hypothetical stressful situations in which their initial thoughts regarding the event are given. Quality scores range from 0 to 6, with a higher score indicating greater CBT skills.
Weeks 0-12, assessments occurred at intake, week 4, and week 12.
Change in CBT Skills - Interview at week 12.
The CBT skills interview is a semi-structured interview based measure of CBT skills. Assessors evaluate the clients CBT skills use over the past two weeks with seven items. This interview assesses client skills in using coping strategies central to CBT. Scores range from 0 to 28, with a higher score indicating greater CBT skills.
Weeks 0-12, assessments occurred at intake, week 4, and week 12.
Secondary Outcomes (5)
Change in Quick Inventory of Depressive Symptoms-Clinician version at week 12.
Weeks 0-12, assessments occurred at intake, week 4, and week 12.
Change in Cognitive Change Immediate at week 12.
Weeks 0-12, assessments occurred at every session through week 12.
Change in Competencies of Cognitive Therapy Scale - client version at week 12.
Weeks 0-12, assessments occurred at intake, week 4, and week 12.
Change in Competencies of Cognitive Therapy Scale - therapist version at week 12.
Weeks 0-12, assessments occurred at intake, week 4, and week 12.
Change in Work Social Adjustment Scale at week 12.
Weeks 0-12, assessments occurred at intake, week 4, and week 12.
Other Outcomes (1)
Time to relapse per modified version of the Patient Health Questionnaire
Immediately post-treatment to 6 months post treatment. Assessments occurred monthly following the posttreatment evaluation
Study Arms (2)
Cognitive Behavioral Therapy (CBT)
ACTIVE COMPARATORCognitive behavioral therapy will be provided as described in Beck et al. (1979) and Beck (2011), with adaptations for the treatment of comorbid personality disorders as described in Beck et al. (2015).
Cognitive Behavioral Therapy - Skill enhanced (CBT-SE)
ACTIVE COMPARATORThis condition includes a variation of CBT (as provided in the other condition) with special emphasis on helping clients to develop the skills of CBT.
Interventions
In light of COVID-19 considerations, interventions are currently being provided via telehealth technology.
Eligibility Criteria
You may qualify if:
- diagnosis of major depressive disorder (MDD) according to DSM-5 criteria;
- years old or older;
- residence in the state of Ohio;
- access to a reliable internet connection (to participate in virtual sessions); and
- being able and willing to give informed consent.
You may not qualify if:
- current or past diagnosis of bipolar disorder or a psychotic disorder;
- moderate or severe substance use in the past 6 months (where "moderate" is defined as 4-5 symptoms and "severe" is defined as 6 + symptoms of those listed in DSM-5 for each of the substance-related disorders);
- current disorder other than MDD if it constitutes the predominant aspect of the clinical presentation and if it requires treatment other than that being offered;
- currently participating in a treatment for an emotional disorder, including any individual psychotherapy or psychiatric medications used to treat a mood or anxiety disorders;
- clear indication of secondary gain (e.g., court-ordered treatment); and
- current suicide risk or significant intentional self-harm in the last six months sufficient to preclude treatment on an outpatient basis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Psychology, The Ohio State University
Columbus, Ohio, 43210, United States
Related Publications (1)
Beck AT, Rush AJ, Shaw BF, Emery G. (1979). Cognitive Therapy of Depression. Guilford.
BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel R Strunk, PhD
Ohio State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 12, 2020
First Posted
December 17, 2020
Study Start
December 11, 2020
Primary Completion
November 8, 2022
Study Completion
April 19, 2023
Last Updated
April 18, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
We will consider requests for data sharing, pending approval from our IRB.